Author Question: A researcher develops a study to examine the effects of Keep Yourself Safe Screening (KYSS) on the ... (Read 78 times)

K@

  • Hero Member
  • *****
  • Posts: 608
A researcher develops a study to examine the effects of Keep Yourself Safe Screening (KYSS) on the incidence of intimate partner violence (IPV). The study level of significance is 0.05.
 
  The null hypothesis, that KYSS will have no effect on IPV, is found to be true. When reviewing the study for Type II errors, the reviewer understands that:
  a. a level of significance of 0.01 would decrease the risk of a Type II error.
  b. the level of significance does not affect the chance of a Type II error.
  c. there is a 5 chance that the null hypothesis is false.
  d. there is a 5 chance that the null hypothesis is true.

Question 2

When a researcher concludes that study findings are applicable to the total population, this is an example of
 
  a. generalization.
  b. inference.
  c. probability.
  d. significance.



ynlevi

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

ANS: C

Answer to Question 2

ANS: A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

For a complete list of videos, visit our video library